Effect of low-molecular-weight heparin on survival in patients with advanced pancreatic adenocarcinoma

Stefan von Delius, Muhammed Ayvaz, Stefan Wagenpfeil, Florian Eckel, Roland M. Schmid, Christian Lersch

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Abstract

This retrospective analysis aimed to identify whether low-molecular-weight heparins (LMWH) might improve survival in patients receiving chemotherapeutic treatment for advanced pancreatic adenocarcinoma. Two hundred forty-three patients who had received chemotherapy for advanced pancreatic adenocarcinoma were identified from a prospectively maintained database. Of these, 30 patients had to be excluded from analysis due to insufficient documentation. Of the remaining 213 patients 94 patients had been treated with LMWH, whereas 119 patients served as controls. Outcome was assessed in relation to overall survival, which was calculated from the date of initiation of chemotherapy to the date of death. There was no significant difference (hazard ratio, 0.8; 95% confidence interval (CI), 0.6 to 1.1; P=0,2) between the two groups in terms of overall survival. The median survival was 7.1 months (95% CI, 5.8-8.4 months) in the LMWH group and 5.9 months (95% CI, 5.1-6.7 months) in the non-LMWH group. A positive effect of LMWH was seen in patients with metastatic disease (hazard ratio for LMWH vs. non-LMWH, 0,6; 95% CI, 0,4 to 0,8; P=0,006) in contrast to those without metastatic disease (hazard ratio for LMWH vs. non-LMWH, I; 95% CI, 0.6 to 1.7; P=0,96).The median survival of patients with metastatic disease was 6,6 months (95% CI, 5-8,2 months) and 3.8 months (95% CI, 2.5-5.1 months) for the LMWH group and the non-LMWH group, respectively. In conclusion, we found for metastatic pancreatic adenocarcinoma a survival advantage for patients receiving LMWH. Nevertheless, our observations need confirmation by prospective randomized studies.

Original languageEnglish
Pages (from-to)434-439
Number of pages6
JournalThrombosis and Haemostasis
Volume98
Issue number2
DOIs
StatePublished - Aug 2007

Keywords

  • Low-molecular-weight heparin
  • Metastasis
  • Pancreatic adenocarcinoma
  • Survival

Fingerprint

Dive into the research topics of 'Effect of low-molecular-weight heparin on survival in patients with advanced pancreatic adenocarcinoma'. Together they form a unique fingerprint.

Cite this